Aardvark Therapeutics, Inc.

AARD

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001774857

SEC filings (opens in a new tab)

Insider trades, last 90 days

0 buys · 1 sell

Sold $394.96K
Open-market purchases (P) and sales (S), counted by Form 4 filing.

View insider trades

13F holders, Q2 2026

71

−8 vs. Q1 2026
Total value $55.01M

View 13F holders

Superinvestors holding AARD

0

None of the superinvestors held AARD at the end of Q2 2026.

See all holders

Price chart

Chart by TradingView (opens in a new tab)

Latest insider trades

Open-market purchases and sales by AARD insiders, newest first.

Insider trades
Filed (ET)	Trade date	Insider	Transaction	Shares	Avg price	Value	Shares after	Holding change	Filing
Sep 11, 20268:14 PM ET	Sep 10 – Sep 11, 2026	Sun NelsonSee Remarks	SSaleCommon Stock, par value $0.00001 per share	−76.75K	$5.1458	−$394.96K	35.48K	−68.4%	SEC10b5-1
Dec 12, 2025	Dec 11, 2025	Sun NelsonChief Financial Officer	PPurchaseCommon Stock	+3K	$14.40	+$43.2K	108.48K	+2.8%	SEC
Dec 12, 2025	Dec 11, 2025	Lee Tien-LiChief Executive Officer	PPurchaseCommon Stock	+7K	$14.49	+$101.43K	1.55M	+0.5%	SEC
Sep 16, 2025	Sep 15, 2025	Lee Tien-LiChief Executive Officer	PPurchaseCommon Stock	+10K	$9.6605	+$96.61K	1.54M	+0.7%	SEC
Sep 12, 2025	Sep 10 – Sep 12, 2025	Lee Tien-LiChief Executive Officer	PPurchaseCommon Stock	+20K	$8.0305	+$160.61K	1.53M	+1.3%	SEC

Top 5 13F holders, Q2 2026

The largest institutional positions in AARD at the end of Q2 2026.

Institutions holding AARD in Q2 2026
Institution	Shares	Value	% of portfolio	Change in shares	Action
Decheng Capital LLC	3,917,299	$22.56M	3.08%	00.0%	Unchanged
CITADEL ADVISORS LLC	1,283,166	$7.39M	0.00%	+40,389+3.2%	Added
Laurion Capital Management LP	1,034,459	$5.96M	0.43%	00.0%	Unchanged
VANGUARD CAPITAL MANAGEMENT LLC	562,877	$3.24M	0.00%	+8,776+1.6%	Added
AQR CAPITAL MANAGEMENT LLC	480,249	$2.77M	0.00%	+345,754+257.1%	Added